Upgrade to SI Premium - Free Trial

Eli Lilly & Co. (LLY) Could be the Beneficiary of Pfizer's (PFE) Ibrance Setback - Goldman Sachs

June 1, 2020 7:56 AM
Goldman Sachs analyst, Terence Flynn, believes Eli Lilly & Co. (NYSE: LLY) is likely to be the beneficiary from Pfizer's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments

Next Articles